Page last updated: 2024-09-03

5-fluoro-2,2'-cyclocytidine and Leukemia, Myeloid, Acute

5-fluoro-2,2'-cyclocytidine has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arlin, Z; Burchenal, JH; Clarkson, B; Comacho, E; Dowling, M; Drapkin, RL; Dufour, P; Gee, TS; Kempin, S; McKenzie, S; Mertelsmann, R; Oettgen, HF; Passe, S; Thaler, HT; To, L1
Meyers, PA; Redner, A; Steinherz, PG; Tan, CT1

Trials

1 trial(s) available for 5-fluoro-2,2'-cyclocytidine and Leukemia, Myeloid, Acute

ArticleYear
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
    Cancer, 1981, Nov-15, Volume: 48, Issue:10

    Topics: Adolescent; Adult; Aged; Ancitabine; Antineoplastic Agents; Bacterial Vaccines; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Pseudomonas aeruginosa; Random Allocation; Thioguanine

1981

Other Studies

1 other study(ies) available for 5-fluoro-2,2'-cyclocytidine and Leukemia, Myeloid, Acute

ArticleYear
Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
    Cancer, 1989, Dec-15, Volume: 64, Issue:12

    Topics: Adolescent; Ancitabine; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow; Cell Survival; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male

1989